Profit saw 4% hike in 2024, Prodia unveils strategy for this year
18 days ago
Prodia's (PRDA) revenue rose by only 1.3%, while profit grew by 4%. What's its strategy for 2025?
PRDA to take subsidiary public
a month ago
Prodia readies its subsidiary, Proline, to debut on the stock market in the next 2-3 years.
Securing medical device supply chain, Prodia spends IDR 72 billion on 39% of Proline
9 months ago
PT Prodia Widyahusada Tbk (PRDA) takes an extra measure to secure supply chain of in vitro diagnostic (IVD) test tools by acquiring 39% of its affiliate, PT Prodia Diagnostic Line (Proline).
Prodia Diagnostic Line hosts topping-off for new production facility, targeting TKDN above 60%
9 months ago
PT Prodia Diagnostic Line (Proline), "sister company" of PT Prodia Widyahusada Tbk (PRDA) which is engaged in manufacturing reagents and test equipment, has just held the topping off of its newest production facility building today (25/6) in the Jababeka area, Cikarang.
Hesitating on IKN, Prodia allocates 55% of capex to IT
a year ago
PT Prodia Widyahusada Tbk (PRDA) has prepared moderate amount of capital expenditure (capex) in 2024, worth a maximum of IDR 250 billion.